MedTrace Logo

Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis

NCT00913315 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2009-06-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether tamsulosin and tolterodine are effective in the treatment of men with lower urinary tract symptoms and chronic prostatitis/chronic pelvic pain syndrome.

Conditions

  • Prostatitis

Interventions

DRUG

tolterodine

4 mg of tolterodine ER

DRUG

tamsulosin

0.4 mg of tamsulosin once a day for 8 weeks

DRUG

placebo

placebo once a day for 8 weeks

Sponsors & Collaborators

  • Fuling Central Hospital of Chongqing City

    collaborator OTHER

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Yong Chen, M.D. · Chongqing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-10-31
Completion
2010-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913315 on ClinicalTrials.gov